Page 1

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - Q × QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30 , 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39725 Delaware Maravai LifeSciences Holdings , Inc. ( Exact name of registrant as specified in its charter ) ( State or other jurisdiction of incorporation or organization ) 10770 Wateridge Circle Suite 200 San Diego , California ( Address of principal executive offices ) 8731 ( Primary Standard Industrial Classification Code Number ) 85-2786970 ( I.R.S. Employer Identification No. ) 92121 ( Zip code ) Registrant's telephone number , including area code : ( 858 ) 546-0004 Securities registered pursuant to Section 12 ( b ) of the Act : Title of each class Class A common stock , $ 0.01 par value Trading Symbol ( s ) MRVI Name of each exchange on which registered The Nasdaq Stock Market LLC Securities registered pursuant to section 12 ( g ) of the Act : None Indicate by check mark whether the registrant : ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) ; and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes x No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes No □ Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See the definitions of “ large accelerated filer , ” “ accelerated filer ” and “ smaller reporting company ” in Rule 12b - 2 of the Exchange Act . ( Check one ) : Large accelerated filer Non - accelerated filer O Accelerated filer Smaller reporting company Emerging growth company O If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . O Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes No x As of November 5 , 2021 , 131,458,704 shares of the registrant's Class A common stock were outstanding and 126,239,611 shares of the registrant's Class B common stock were outstanding . 1